Black Rock Inc. Pardes Biosciences, Inc. Transaction History

Black Rock Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$1.4 - $1.95 $1.99 Million - $2.78 Million	-1,423,653 Reduced 75.71%	456,689 $826,000
Q1 2023 May 12, 2023	SELL	$1.21 - $2.22 $59,293 - $108,786	-49,003 Reduced 2.54%	1,880,342 $2.48 Million
Q4 2022 Feb 13, 2023	BUY	$0.85 - $1.69 $47,244 - $93,933	55,582 Added 2.97%	1,929,345 $3.26 Million
Q3 2022 Nov 14, 2022	BUY	$2.14 - $3.7 $573,879 - $992,221	268,168 Added 16.7%	1,873,763 $3.47 Million
Q2 2022 Aug 12, 2022	BUY	$2.84 - $8.57 $3.58 Million - $10.8 Million	1,261,808 Added 367.03%	1,605,595 $4.93 Million
Q1 2022 May 12, 2022	BUY	$5.64 - $15.64 $1.94 Million - $5.38 Million	343,787 New	343,787 $2.48 Million

5.23M

Ticker PRDS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,320,900
Description
Pardes Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics to improve the lives of patients suffering from life-threatening disease. Its lead candidate is the PBI-0451 that is in clinical development stage to treat and prevent severe acute respiratory syndrome ...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.